China Universal Asset Management Company’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17M | Buy |
149,162
+1,196
| +0.8% | +$25.5K | 0.3% | 68 |
|
|
2025
Q1 | $2.85M | Sell |
147,966
-8,400
| -5% | -$162K | 0.27% | 81 |
|
|
2024
Q4 | $2.79M | Buy |
156,366
+17,014
| +12% | +$304K | 0.26% | 81 |
|
|
2024
Q3 | $3.05M | Buy |
139,352
+56,879
| +69% | +$1.25M | 0.34% | 67 |
|
|
2024
Q2 | $643K | Sell |
82,473
-52,372
| -39% | -$409K | 0.09% | 129 |
|
|
2024
Q1 | $558K | Buy |
134,845
+53,774
| +66% | +$223K | 0.07% | 174 |
|
|
2023
Q4 | $212K | Buy |
81,071
+63,168
| +353% | +$165K | 0.04% | 199 |
|
|
2023
Q3 | $33.5K | Buy |
17,903
+8,758
| +96% | +$16.4K | 0.01% | 258 |
|
|
2023
Q2 | $23K | Sell |
9,145
-308
| -3% | -$773 | 0.01% | 255 |
|
|
2023
Q1 | $16.5K | Buy |
9,453
+7,408
| +362% | +$13K | 0.01% | 241 |
|
|
2022
Q4 | $8.69K | Buy |
2,045
+160
| +8% | +$680 | ﹤0.01% | 242 |
|
|
2022
Q3 | $2K | Buy |
+1,885
| New | +$2K | ﹤0.01% | 358 |
|